Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Int J Clin Pharm. 2022 Feb;44(1):64-71. doi: 10.1007/s11096-021-01313-3. Epub 2021 Aug 17.
Background Pharmacists' interventions (PI) are suitable to improve medication safety and optimise patient outcome. However, in Germany, clinical pharmacy services are not yet available nationwide. Aim To gain prospective data on the extent and the composition of routine PI with special focus on intervention rates among German hospital pharmacists during two intervention weeks. Methods Within a repetitive cross-sectional study, clinical pharmacists documented all PIs on five days during a one-month period (intervention week) in 2017 and 2019 using the validated online-database ADKA-DokuPIK. Additionally, data regarding the supply structure/level of medical care, the extent of clinical pharmacy services and their professional experience were collected. All data were anonymised before analysis. Results In total, 2,282 PI from 62 pharmacists (2017) and 2578 PI from 52 pharmacists (2019) were entered. Intervention rate increased from 27.5 PI/100 patient days in 2017 to 38.5 PI/100 patient days in 2019 (p = 0.0097). Frequency of clinical pharmacy services on a daily basis significantly increased from 60% (2017) to 83% (2019). Reasons for PIs from the categories "drugs" (e.g. indication, choice, documentation/transcription) and "dose" were most common in both intervention weeks. The vast majority of underlying medication errors in both intervention weeks were categorised as "error, no harm" (80.3 vs. 78.6%), while the proportion of errors which did not reach the patient, doubled to 39.8% in IW-2019. Conclusion Regular and daily clinical pharmacy services become more established in Germany and clinical pharmacists are increasingly involved in solving drug related problems proactively and early during the medication management process.
药剂师的干预措施(PI)适合提高用药安全性并优化患者的治疗效果。然而,在德国,全国范围内尚未提供临床药学服务。目的:获取关于德国医院药剂师在两个干预周内常规 PI 的范围和组成的前瞻性数据,特别关注干预率。方法:在一项重复性横断面研究中,临床药师在 2017 年和 2019 年的一个月期间(干预周)使用经过验证的在线数据库 ADKA-DokuPIK 在五天内记录所有 PI。此外,还收集了有关供应结构/医疗水平、临床药学服务范围及其专业经验的数据。所有数据在分析前均进行了匿名处理。结果:共记录了 62 名药师(2017 年)的 2282 项 PI 和 52 名药师(2019 年)的 2578 项 PI。2017 年每 100 个患者日的干预率为 27.5 项,2019 年增加到 38.5 项(p=0.0097)。每天提供临床药学服务的频率从 60%(2017 年)增加到 83%(2019 年)。两个干预周中,PI 最常见的原因来自“药物”(例如,适应证、选择、记录/转录)和“剂量”类别。两个干预周中,绝大多数潜在药物错误都被归类为“无伤害的错误”(80.3%对 78.6%),而未送达患者的错误比例增加到 2019 年干预周的 39.8%。结论:在德国,定期和日常的临床药学服务变得更加成熟,临床药师越来越多地参与到主动和尽早解决与药物相关的问题,以优化药物管理过程。